NRIX
NASDAQ
$22.71
Nurix Therapeutics Inc (NRIX)
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company is headquartered in San Francisco, California.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $32.50 (+43.11%)
Market Cap
$2.47B
FCF 5Y CAGR
+40.50%
Free Cash Flow Yield
-12.31%
Beta (5Y)
1.36
Price Chart
Valuation
Market Cap$2.47B
P/S67.32
P/B5.92
Profitability
Total Revenue (TTM)$37M
Gross Profit (TTM)-$304M
EBITDA-$354M
Operating Margin-1042%
EPS-$3.60
Financial Health
Free Cash Flow Yield-12.31%
Growth & Risk
EPS 5Y CAGR+10.31%
Revenue 5Y CAGR+9.95%
FCF 5Y CAGR+40.50%
Beta (5Y)1.36
Sharpe Ratio1.25